| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | -0.042 | 0.4 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.038 | 0.4 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.4 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | 0.023 | 0.4 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.025 | 0.4 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.5 |